Janux Therapeutics, Inc. (JANX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 855.14M |
| Enterprise Value | 824.95M |
| P/E Ratio | -10.6 |
| PEG Ratio | -1.49 |
| Price/Sales Ratio | 33.27 |
| Price/Book Ratio | 1.18 |
| Enterprise/Revenue | 33.05 |
| Enterprise/EBITDA | -10.42 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -3.22 |
| Operating Margin | -4.5 |
| Return On Assets | -0.1 |
| Return On Equity | -0.11 |
| Revenue | 10M |
| Revenue/Share | 0.51 |
| Gross Profit | 7.97M |
| EBITDA | -111.6M |
| Net Income | -113.63M |
| Diluted EPS | -1.83 |
| Total Cash | 970.91M |
| Total Cash/Share | 15.43 |
| Total Debt | 20.99M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 16.35 |
| Book Value Per Share | 14.74 |
| 52-Week Change | -28.44 |
| 52-Week High | 35.34 |
| 52-Week Low | 12.12 |
| Moving Average 50 Days | 15.61 |
| Moving Average 200 Days | 16.03 |
| Average Volume | 988,022 |
| Shares Outstanding | 60.98M |
| % Held by Institutions | 97.49 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |